Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re Pohl
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(D) of The Securities Exchange Act of 1934
Date of report (Date of earliest event reported): February 7, 2008
Patriot Scientific Corporation
(Exact name of registrant as specified in its charter)
Delaware |
0-22182 |
84-1070278 |
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
Carlsbad Corporate Plaza
6183 Paseo Del Norte, Suite 180
Carlsbad, CA 92011
(Address of principal executive offices, zip code)
(760) 547-2700
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (127 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 7, 2008, Mr. David Pohl, the chairman of the board of directors (the “Board”) of Patriot Scientific Corporation (the “Company”), notified the Board by letter that he was resigning his position as chairman and as a member of the Board in order to spend more time on personal and family matters. A copy of the letter from Mr. Pohl is attached hereto as Exhibit 99.1.
The Company expressly disclaims any obligation to update this letter and cautions that it is only accurate on the date it was presented. The inclusion of any data or statements in this letter does not signify that the information is considered material.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Letter dated February 7, 2008
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Patriot Scientific Corporation
(Registrant)
|
|||
Date: February 8, 2008 |
By: |
/s/ Clifford Flowers | |
| Clifford Flowers | |||
| Chief Financial Officer | |||
Exhibit 99.1
David H. Pohl
6965 El Camino Real, Ste. 105-213
david@pohlgroup.com
February 7, 2008
To the Board of Directors, Patriot Scientific Corporation:
Carlton M Johnson, Jr., Chairman, Executive Committee
Gloria H. Felcyn
Helmut Falk, Jr.
Jim Turley
Nicholas Tredennick
Dear Board Members,
This letter will serve as my formal resignation from the Board of Directors of Patriot Scientific Corporation.
The decision to resign has come after careful consideration, and I have concluded that it is time for me to leave the board and make room for new blood to join the team that will guide the company as it continues along its dynamic future path.
This is the final step in a withdrawal process that began when I retired as CEO in June of 2007. Leaving the board will now make my retirement from Patriot complete, with the freedom to spend more time on personal and family matters.
I will always appreciate the challenges and opportunities for personal and professional growth that I have experienced while being associated with Patriot, in addition to the many friends and acquaintances that I have met along the way. The company has been a significant part of my life for the past seven years, so it is with considerable emotion that I move on.
This resignation is effective immediately.
Sincerely,
Cc: Clifford Flowers, Corporate Secretary
Otto E. Sorenson, Esq., General Counsel
Charles T. Hoge, Litigation Counsel
Be well
New Message
Please
login
to post a reply